Update – Advocacy in Action!
The United States Senate Committee of Finance released their report titled "Deceptive Marketing Practices Flourish in Medicare Advantage" and excerpts from...
UPDATE – Payer Barriers Limit Timely Access
PAYER BARRIERS LIMIT TIMELY ACCESS Authored by Aurinia Pharma U.S., Inc. Timely access to therapy can be difficult to achieve....
Update: SAPHNELO Policy Acumen Portal
The SAPHNELO Policy Acumen Portal provides up-to-date resources for billing, coding, and coverage policies specific to preselected payers. The link...
U.S. Renews COVID-19 Public Health Emergency
Access Full Article from Reuters - Here
UPDATE: SAPHNELO – New Permanent J Code
UPDATE! New Permanent J Code for SAPHNELO (anifrolumab-fnia) injection, for intravenous use, 300 mg/2mL The Centers for Medicare and Medicaid...
Connecting with Cosentyx
IN LUPUS NEPHRITIS, REDUCE RISK FROM THE START – AIM FOR PROMPT PROTEINURIA REDUCTIONS
Authored by Aurinia Pharma U.S., Inc.Lupus nephritis (LN), a common and serious complication of systemic lupus erythematosus (SLE), occurs when...
Five Essential Ideas for Updating your Rheumatology Website in 2019
Every day, people are swarming the internet to find the things they are searching for. Whether it’s a hot new...
Why You Should Attend NORM’s 2018 Conference
Each year, NORM hosts an annual conference that brings together the best and brightest in the industry. This year we...
Genetech-Access Solutions
Genentech Access Solutions is your resource for reliable, effective access and reimbursement support. We are committed to providing personal support...
New Treatment Options for SIMPONI ARIA®
Today Janssen has received U.S. FDA approval of SIMPONI ARIA® for the treatment of adults living with active psoriatic arthritis (PsA)...
Contact
- As a speaker at the first ad hoc meeting of rheumatology practice managers gathered in a single small room at its infancy a decade ago, I’m amazed to see how NORM has blossomed into a high energy organization of depth and professional meetings with parallel break-out symposia between plenary sessions. NORM has truly come of age. This is where the “business” of rheumatology gets learned. The ”guildmanship” for rheumatology practice management is now strong.- Paul H. Caldron, DO, FACP, FACR, MBA, Arizona Arthritis and Rheumatology Associates
- In a time of demanding changes in the management of medical practices in the US, NORM has been a lifesaver to the community of Rheumatology practices. NORM has allowed our practice to stay ahead of the many demands of CMS and others payors and has ensured that our practice remains cognizant of new issues that arise in HIPPA compliance, human resources and medical billing to name a few. Sending our Practice Manager to NORM's conferences has been cost-effective and beneficial to our practice because she returns to our office with an abundance of information that otherwise would have taken months to compile. Every Rheumatology practice that wishes to stay on top of emerging issues in practice management should consider sending a member of their staff to NORM's conference.- Michael S. Rosen M.D., Chester County Rheumatology PC
- Thanks to all those wonderful people in the NORM Network who respond to emails, offering their advice, experience, time, and support ... I haven't even been a member a full year yet and I am amazed at the dedication of everyone who responds to helping via emails and the NORM Organization itself! I have barely had a chance to explore the resources and I have yet to really dive into requests for help still I am silently learning so much and do occasionally offer what I can! Thank you all!- Cheryl Piambino, Kenneth E. Bresky, DO
What We Offer
We’re adding value to practices across the nation by creating a thriving community of rheumatology managers and physicians.
Membership Benefits
Become a Member
Annual Conference
Conference Registration
